Dr. Botvin is also Director of Cornell’s Institute for Prevention Research, Chief of the Division of Prevention and Health Behavior, and an Attending Psychologist at the New York Presbyterian Hospital. He is the author or co-author of 200 articles in scientific journals and book chapters. His groundbreaking work in the area of drug abuse prevention has received national and international attention. He has been an invited speaker at major scientific conferences around the world and has served as a consultant to the National Institute on Drug Abuse, the U.S. Department of Education, the Centers for Disease Control and Prevention, the Center for Substance Abuse Prevention, the National Cancer Institute, the White House Office on Drug Policy, and the World Health Organization. Dr. Botvin received the FBI’s national leadership award for his work in drug abuse prevention (1994), received a prestigious MERIT award from the National Institute on Drug Abuse for his achievements as an outstanding prevention researcher (1996), and received the Society for Prevention Research’s Presidential Award for prevention research excellence (1998). He was recently elected President of the Society for Prevention Research, an international professional organization of prevention researchers, policy makers, and practitioners. Dr. Botvin is also editor-in-chief of Prevention Science, an international peer-reviewed scientific journal.

In addition to being the developer of the LST program and a faculty member of Cornell’s Weill Medical College, Dr. Botvin is the founder and president of National Health Promotion Associates, Inc. (NHPA). NHPA is a health consulting and training firm involved in the development, training, and marketing of the LST program. Weill Medical College of Cornell University does not specifically support or endorse either entity.